Evaluation of the Dopamine Hypothesis of ADHD with PET Brain Imaging
- 1. University of California, Irvine, CA (United States)
Description
The Dopamine (DA) Hypothesis of ADHD (Wender, 1971; Levy, 1990) suggests that abnormalities in the synaptic mechanisms of DA transmission may be disrupted, and specific abnormalities in DA receptors and DA transporters (DAT) have been proposed (see Swanson et al, 1998). Early studies with small samples (e.g., n = 6, Dougherty et al, 1999) used single photon emission tomography (SPECT) and the radioligand (123I Altropane) to test a theory that ADHD may be caused by an over expression of DAT and reported 'a 70% increase in age-corrected dopamine transporter density in patients with attention deficit hyperactivity disorder compared with healthy controls' and suggested that treatment with stimulant medication decreased DAT density in ADHD patients and corrected an underlying abnormality (Krause et al, 2000). The potential importance of these findings was noted by Swanson (1999): 'If true, this is a major finding and points the way for new investigations of the primary pharmacological treatment for ADHD (with the stimulant drugs - e.g., methylphenidate), for which the dopamine transporter is the primary site of action. The potential importance of this finding demands special scrutiny'. This has been provided over the past decade using Positron Emission Tomography (PET). Brain imaging studies were conducted at Brookhaven National Laboratory (BNL) in a relatively large sample of stimulant-naive adults assessed for DAT (11C cocaine) density and DA receptors (11C raclopride) availability. These studies (Volkow et al, 2007; Volkow et al, 2009) do not confirm the hypothesis of increased DAT density and suggest the opposite (i.e., decreased rather than increased DAT density), and follow-up after treatment (Wang et al, 2010) does not confirm the hypothesis that therapeutic doses of methylphenidate decrease DAT density and suggests the opposite (i.e., increased rather than decreased DAT density). The brain regions implicated by these PET imaging studies also suggest that a motivation deficit may contribute as much as an attention deficit to the manifestation of behaviors that underlie the symptoms of ADHD.
Availability note (English)
Available from Video. rtsp://vmsstreamer1.fnal.gov/VMS_Site_03/Lectures/Colloquium/100428Swanson/100428Swanson.rmAdditional details
Publishing Information
- Imprint Pagination
- vp.
Conference
- Title
- Fermilab Colloquia, Fermi National Accelerator Laboratory (FNAL)
- Dates
- 28 Apr 2010
- Place
- Batavia, IL (United States)
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 43060283
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference, Non-conventional Literature
- Descriptors DEI
- ADULTS; AVAILABILITY; BNL; BRAIN; COCAINE; DOPAMINE; EVALUATION; HYPOTHESIS; PATIENTS; PHOTON EMISSION; POSITRONS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYMPTOMS
- Descriptors DEC
- AGE GROUPS; ALKALOIDS; AMINES; ANESTHETICS; ANTIDEPRESSANTS; ANTILEPTONS; ANTIMATTER; ANTIPARTICLES; AROMATICS; AUTONOMIC NERVOUS SYSTEM AGENTS; BODY; CARDIOTONICS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DRUGS; ELEMENTARY PARTICLES; EMISSION; EMISSION COMPUTED TOMOGRAPHY; FERMIONS; HYDROXY COMPOUNDS; LEPTONS; MATTER; NATIONAL ORGANIZATIONS; NERVOUS SYSTEM; NEUROREGULATORS; ORGANIC COMPOUNDS; ORGANS; PHENOLS; POLYPHENOLS; PSYCHOTROPIC DRUGS; SYMPATHOMIMETICS; TOMOGRAPHY; US AEC; US DOE; US ERDA; US ORGANIZATIONS
Optional Information
- Contract/Grant/Project number
- AC02-07CH11359
- Notes
- run time 01:16:54
- Funding organization
- USDOE Office of Science (United States)